Amphastar Pharmaceuticals Return on Investment 2012-2024 | AMPH
Current and historical return on investment (ROI) values for Amphastar Pharmaceuticals (AMPH) over the last 10 years.
| Amphastar Pharmaceuticals ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-09-30 |
$0.21B |
$1.32B |
16.72% |
| 2024-06-30 |
$0.23B |
$1.30B |
18.30% |
| 2024-03-31 |
$0.21B |
$1.27B |
17.64% |
| 2023-12-31 |
$0.20B |
$1.23B |
18.94% |
| 2023-09-30 |
$0.18B |
$1.23B |
20.49% |
| 2023-06-30 |
$0.13B |
$1.08B |
18.20% |
| 2023-03-31 |
$0.12B |
$0.62B |
20.05% |
| 2022-12-31 |
$0.11B |
$0.60B |
18.73% |
| 2022-09-30 |
$0.09B |
$0.58B |
16.89% |
| 2022-06-30 |
$0.10B |
$0.57B |
17.84% |
| 2022-03-31 |
$0.08B |
$0.55B |
15.78% |
| 2021-12-31 |
$0.07B |
$0.52B |
13.95% |
| 2021-09-30 |
$0.05B |
$0.51B |
9.95% |
| 2021-06-30 |
$0.03B |
$0.50B |
5.75% |
| 2021-03-31 |
$0.01B |
$0.48B |
2.91% |
| 2020-12-31 |
$0.01B |
$0.48B |
2.31% |
| 2020-09-30 |
$0.01B |
$0.48B |
1.69% |
| 2020-06-30 |
$0.01B |
$0.48B |
1.28% |
| 2020-03-31 |
$0.01B |
$0.46B |
2.14% |
| 2019-12-31 |
$0.00B |
$0.47B |
0.00% |
| 2019-09-30 |
$0.00B |
$0.47B |
0.46% |
| 2019-06-30 |
$0.00B |
$0.47B |
0.73% |
| 2019-03-31 |
$-0.00B |
$0.41B |
-0.26% |
| 2018-12-31 |
$-0.01B |
$0.40B |
-2.15% |
| 2018-09-30 |
$-0.01B |
$0.37B |
-3.27% |
| 2018-06-30 |
$-0.02B |
$0.35B |
-4.90% |
| 2018-03-31 |
$-0.01B |
$0.37B |
-3.49% |
| 2017-12-31 |
$-0.00B |
$0.38B |
-0.54% |
| 2017-09-30 |
$-0.01B |
$0.37B |
-1.37% |
| 2017-06-30 |
$0.00B |
$0.37B |
1.10% |
| 2017-03-31 |
$0.01B |
$0.36B |
3.38% |
| 2016-12-31 |
$0.02B |
$0.36B |
4.32% |
| 2016-09-30 |
$0.03B |
$0.36B |
10.04% |
| 2016-06-30 |
$0.02B |
$0.34B |
7.35% |
| 2016-03-31 |
$0.00B |
$0.33B |
1.24% |
| 2015-12-31 |
$-0.01B |
$0.33B |
-2.19% |
| 2015-09-30 |
$-0.03B |
$0.32B |
-8.83% |
| 2015-06-30 |
$-0.03B |
$0.32B |
-10.02% |
| 2015-03-31 |
$-0.02B |
$0.32B |
-7.14% |
| 2014-12-31 |
$-0.02B |
$0.32B |
-5.83% |
| 2014-09-30 |
$-0.01B |
$0.32B |
-2.72% |
| 2014-06-30 |
$0.00B |
$0.33B |
0.00% |
| 2014-03-31 |
$0.01B |
$0.26B |
9.94% |
| 2013-12-31 |
$0.02B |
$0.26B |
25.95% |
| 2013-09-30 |
$0.07B |
|
106.02% |
| 2013-06-30 |
$0.12B |
|
197.59% |
| 2013-03-31 |
$0.16B |
|
257.03% |
| 2012-12-31 |
$0.20B |
$0.25B |
327.71% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
